89bio, Inc. - Common stock, par value $0.001 per share (ETNB)
CUSIP: 282559103
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common stock, par value $0.001 per share
- Shares outstanding
- 148,275,293
- Total 13F shares
- 32,453,686
- Share change
- +15,387,685
- Total reported value
- $104,561,000
- Put/Call ratio
- 0%
- Price per share
- $3.22
- Number of holders
- 67
- Value change
- +$48,026,442
- Number of buys
- 50
- Number of sells
- 35
Quarterly Holders Quick Answers
What is CUSIP 282559103?
CUSIP 282559103 identifies ETNB - 89bio, Inc. - Common stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 282559103:
Top shareholders of ETNB - 89bio, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
3/4/5
13F
|
10%+ Owner · Company |
2.5%
from 13F
|
1,829,436
|
$21,093,397 | — | 25 Jan 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
3.3%
|
4,965,769
|
$18,721,000 | — | 31 Mar 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.2%
|
1,782,053
|
$6,718,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.62%
|
922,203
|
$3,476,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
0.48%
|
712,210
|
$2,684,000 | — | 31 Mar 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.28%
|
419,560
|
$1,582,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.28%
|
418,649
|
$1,578,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.28%
|
413,119
|
$1,558,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.27%
|
405,419
|
$1,529,000 | — | 31 Mar 2022 | |
| Pekin Hardy Strauss, Inc. |
13F
|
Company |
0.24%
|
360,860
|
$1,360,000 | — | 31 Mar 2022 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.22%
|
324,053
|
$1,222,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.18%
|
263,400
|
$993,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.17%
|
249,752
|
$941,000 | — | 31 Mar 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.15%
|
220,418
|
$831,000 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.12%
|
173,400
|
$654,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
167,942
|
$633,000 | — | 31 Mar 2022 | |
| Orchard Capital Management, LLC |
13F
|
Company |
0.11%
|
164,293
|
$619,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.1%
|
148,630
|
$560,000 | — | 31 Mar 2022 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.08%
|
120,271
|
$453,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
98,567
|
$371,000 | — | 31 Mar 2022 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.06%
|
92,815
|
$350,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
70,120
|
$264,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
70,036
|
$264,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
68,217
|
$257,000 | — | 31 Mar 2022 | |
| CSS LLC/IL |
13F
|
Company |
0.04%
|
66,367
|
$250,000 | — | 31 Mar 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.04%
|
65,908
|
$248,000 | — | 31 Mar 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
60,300
|
$227,000 | — | 31 Mar 2022 | |
| XTX Topco Ltd |
13F
|
Company |
0.03%
|
47,147
|
$178,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.03%
|
38,906
|
$149,000 | — | 31 Mar 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.02%
|
35,116
|
$132,000 | — | 31 Mar 2022 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0.02%
|
32,338
|
$121,000 | — | 31 Mar 2022 | |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO |
13F
|
Company |
0.02%
|
32,154
|
$121,000 | — | 31 Mar 2022 | |
| BOURGEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.02%
|
30,950
|
$117,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
30,632
|
$116,000 | — | 31 Mar 2022 | |
| Ram Waisbourd |
3/4/5
|
Chief Operating Officer and Chief Business Officer |
—
mixed-class rows
|
33,750
mixed-class rows
|
$100,888 | — | 17 Feb 2022 | |
| Trexquant Investment LP |
13F
|
Company |
0.02%
|
26,433
|
$100,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
26,265
|
$99,000 | — | 31 Mar 2022 | |
| PDT Partners, LLC |
13F
|
Company |
0.02%
|
23,373
|
$88,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
21,544
|
$81,000 | — | 31 Mar 2022 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.01%
|
21,026
|
$79,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
20,663
|
$78,000 | — | 31 Mar 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
18,932
|
$71,000 | — | 31 Mar 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
18,366
|
$69,000 | — | 31 Mar 2022 | |
| Jump Financial, LLC |
13F
|
Company |
0.01%
|
16,700
|
$63,000 | — | 31 Mar 2022 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.01%
|
16,433
|
$62,000 | — | 31 Mar 2022 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.01%
|
15,000
|
$57,000 | — | 31 Mar 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
13,700
|
$52,000 | — | 31 Mar 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.01%
|
12,700
|
$48,000 | — | 31 Mar 2022 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.01%
|
12,200
|
$46,000 | — | 31 Mar 2022 | |
| MIRABELLA FINANCIAL SERVICES LLP |
13F
|
Company |
0.01%
|
11,400
|
$43,000 | — | 31 Mar 2022 |
Institutional Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q2 2022
As of 30 Jun 2022,
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,453,686 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., BVF INC/IL, ORBIMED ADVISORS LLC, JANUS HENDERSON GROUP PLC, GREAT POINT PARTNERS LLC, BOXER CAPITAL, LLC, TCG Crossover Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC, and VANGUARD GROUP INC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
65
Q2 2022 holders
67
Holder diff
2
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.